TW202045786A - Fiber with cell affinity and fiber product made using the same - Google Patents
Fiber with cell affinity and fiber product made using the same Download PDFInfo
- Publication number
- TW202045786A TW202045786A TW108119206A TW108119206A TW202045786A TW 202045786 A TW202045786 A TW 202045786A TW 108119206 A TW108119206 A TW 108119206A TW 108119206 A TW108119206 A TW 108119206A TW 202045786 A TW202045786 A TW 202045786A
- Authority
- TW
- Taiwan
- Prior art keywords
- fiber
- cell
- section
- affinity
- collagen
- Prior art date
Links
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/01—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with natural macromolecular compounds or derivatives thereof
- D06M15/15—Proteins or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
本發明是有關於一種纖維及使用其所製成的纖維製品,且特別是有關於一種具有細胞親和性的纖維及使用其所製成的纖維製品。The present invention relates to a fiber and a fiber product made from the fiber, and particularly to a fiber with cell affinity and a fiber product made from the fiber.
針對肌腱或韌帶的破裂重建,目前臨床手術以自體肌腱或韌帶搭配軟組織固定裝置為主,肌腱或韌帶的植體需強化克服臨床問題。舉例而言,取自體組織修補,對患者移植部位有一定影響。人工韌帶無法長期植入,易產生磨損及鬆動。此外,現有產品也有生物相容性不足的缺點,例如PET表面親水性差,不利細胞貼附等。另一方面,產品技術需仰賴進口,進而導致成本高昂的問題。In view of the rupture and reconstruction of tendons or ligaments, current clinical operations mainly focus on autogenous tendons or ligaments with soft tissue fixation devices. The implants of tendons or ligaments need to be strengthened to overcome clinical problems. For example, repairing with autologous tissue has a certain impact on the patient's transplantation site. Artificial ligaments cannot be implanted for a long time, and they are easy to wear and loosen. In addition, existing products also have shortcomings of insufficient biocompatibility, such as poor hydrophilicity on the surface of PET and unfavorable cell attachment. On the other hand, product technology must rely on imports, which in turn leads to the problem of high costs.
基於上述,發展出一種能夠增加纖維表面積且具有細胞親和性的纖維,並用以製造人工韌帶等纖維製品,為目前所需研究的重要課題。Based on the above, the development of a fiber that can increase the surface area of the fiber and has cell affinity, and is used to manufacture fiber products such as artificial ligaments, is an important subject for current research.
本發明提供一種具有細胞親和性的纖維及使用其所製成的纖維製品,能夠增加纖維表面積、提升細胞及材料貼覆性並提升細胞組織相容性。The present invention provides a fiber with cell affinity and a fiber product made from the fiber, which can increase the surface area of the fiber, improve the adhesion of cells and materials, and improve the compatibility of cell tissues.
本發明之具有細胞親和性的纖維為經膠原蛋白表面處理的聚對苯二甲酸乙二酯纖維,且具有異形斷面。The cell-affinity fiber of the present invention is a polyethylene terephthalate fiber surface-treated with collagen and has a special-shaped cross section.
在本發明的一實施例中,相對於聚對苯二甲酸乙二酯纖維,膠原蛋白的含量為1 wt%至4 wt%。In an embodiment of the present invention, relative to the polyethylene terephthalate fiber, the content of collagen is 1 wt% to 4 wt%.
在本發明的一實施例中,異形斷面包括十字斷面、一字斷面、波浪形斷面、星形斷面或三角斷面。In an embodiment of the present invention, the special-shaped section includes a cross section, a straight section, a wave section, a star section or a triangular section.
在本發明的一實施例中,相較於圓形斷面,十字斷面使具有細胞親和性的纖維之纖維表面積增加20%至30%,且一字斷面使具有細胞親和性的纖維之纖維表面積增加10 %至20 %。In an embodiment of the present invention, compared to the circular cross section, the cross section increases the fiber surface area of the fiber with cell affinity by 20% to 30%, and the straight cross section increases the fiber surface area of the fiber with cell affinity. The fiber surface area increases by 10% to 20%.
在本發明的一實施例中,相較於圓形斷面,十字斷面使具有細胞親和性的纖維之細胞增生效果增加250%至300%,一字斷面使具有細胞親和性的纖維之細胞增生效果增加250%至300%。In one embodiment of the present invention, the cross section increases the cell proliferation effect of the fiber with cell affinity by 250% to 300% compared to the circular section, and the straight section increases the cell proliferation effect of the fiber with cell affinity. The cell proliferation effect is increased by 250% to 300%.
在本發明的一實施例中,聚對苯二甲酸乙二酯纖維的膠原蛋白表面處理包括:將膠原蛋白溶解於醋酸中,使pH值介於2.5至3.5,再加入PBS以模擬生長環境,以NaOH溶液調整pH值到7至8,使聚對苯二甲酸乙二酯纖維與膠原蛋白反應。In an embodiment of the present invention, the surface treatment of collagen of polyethylene terephthalate fibers includes: dissolving collagen in acetic acid to make the pH between 2.5 and 3.5, and then adding PBS to simulate the growth environment. Adjust the pH value to 7 to 8 with NaOH solution to make the polyethylene terephthalate fiber react with the collagen.
在本發明的一實施例中,膠原蛋白在醋酸中的固含量為0.01wt%至0.1wt%。In an embodiment of the present invention, the solid content of collagen in acetic acid is 0.01 wt% to 0.1 wt%.
在本發明的一實施例中,聚對苯二甲酸乙二酯纖維與膠原蛋白的反應時間為12小時至48小時。In an embodiment of the present invention, the reaction time between polyethylene terephthalate fiber and collagen is 12 hours to 48 hours.
本發明的纖維製品是使用上述具有細胞親和性的纖維所製成,纖維製品包括人工韌帶。The fiber product of the present invention is made by using the above-mentioned cell-affinity fiber, and the fiber product includes an artificial ligament.
在本發明的一實施例中,人工韌帶的編織方法可包括平面編織或立體編織,人工韌帶的強度為1500N至3000N。In an embodiment of the present invention, the weaving method of the artificial ligament may include planar weaving or three-dimensional weaving, and the strength of the artificial ligament is 1500N to 3000N.
基於上述,本發明提供一種具有細胞親和性的纖維,其為經膠原蛋白表面處理的聚對苯二甲酸乙二酯纖維,且具有異形斷面。如此一來,能夠增加纖維表面積、提升細胞及/或材料貼覆性並提升細胞組織相容性。另一方面,本發明也提供一種纖維製品,是使用上述具有細胞親和性的纖維所製成,纖維製品包括人工韌帶。Based on the above, the present invention provides a fiber with cell affinity, which is a polyethylene terephthalate fiber treated with collagen and has a special-shaped cross section. In this way, the surface area of the fiber can be increased, the adhesion of cells and/or materials can be improved, and the cell tissue compatibility can be improved. On the other hand, the present invention also provides a fiber product, which is made by using the above-mentioned cell-affinity fiber, and the fiber product includes an artificial ligament.
為讓本發明的上述特徵和優點能更明顯易懂,下文特舉實施例,並作詳細說明如下。In order to make the above-mentioned features and advantages of the present invention more obvious and understandable, the following embodiments are specially cited and described in detail as follows.
在本文中,由「一數值至另一數值」表示的範圍,是一種避免在說明書中一一列舉所述範圍中的所有數值的概要性表示方式。因此,某一特定數值範圍的記載,涵蓋所述數值範圍內的任意數值以及由所述數值範圍內的任意數值界定出的較小數值範圍,如同在說明書中明文寫出所述任意數值和所述較小數值範圍一樣。In this article, the range represented by "a value to another value" is a summary expression method that avoids listing all the values in the range one by one in the specification. Therefore, the record of a specific numerical range covers any numerical value in the numerical range and the smaller numerical range defined by any numerical value in the numerical range, as if the arbitrary numerical value and the numerical value are clearly written in the specification. The smaller numerical range is the same.
本發明提供一種具有細胞親和性的纖維,其為經膠原蛋白表面處理的聚對苯二甲酸乙二酯纖維,且具有異形斷面。更詳細而言,異形斷面可包括十字斷面、一字斷面、波浪形斷面、星形斷面或三角斷面,但本發明並不以此為限。相較於圓形斷面,十字斷面可使具有細胞親和性的纖維之纖維表面積增加例如20%至30%,且一字斷面可使具有細胞親和性的纖維之纖維表面積增加例如10 %至20 %。相較於圓形斷面,十字斷面可使具有細胞親和性的纖維之細胞增生效果增加例如250%至300%,一字斷面可使具有細胞親和性的纖維之細胞增生效果增加例如250%至300%。圓形斷面的纖維直徑例如是15 μm至20 μm,十字斷面的纖維直徑例如是15 μm至25 μm,一字斷面的纖維直徑例如是20 μm至30 μm。在此需特別說明的是,上述一字斷面纖維在其成型過程中,會受到加工條件的影響而具有捲曲或波浪型的長條型外觀,而並非具有平滑表面的長方體結構。The invention provides a fiber with cell affinity, which is a polyethylene terephthalate fiber treated with collagen and has a special-shaped section. In more detail, the special-shaped section may include a cross section, a straight section, a wavy section, a star-shaped section or a triangular section, but the present invention is not limited thereto. Compared with the circular cross section, the cross section can increase the fiber surface area of the fiber with cell affinity by, for example, 20% to 30%, and the straight cross section can increase the fiber surface area of the fiber with cell affinity by, for example, 10%. To 20%. Compared with the circular section, the cross section can increase the cell proliferation effect of fiber with cell affinity, for example, 250% to 300%, and the straight section can increase the cell proliferation effect of fiber with cell affinity, for example, 250 % To 300%. The fiber diameter of the circular section is, for example, 15 μm to 20 μm, the fiber diameter of the cross section is, for example, 15 μm to 25 μm, and the fiber diameter of the straight section is, for example, 20 μm to 30 μm. It should be particularly noted that the above-mentioned in-line cross-section fiber will be affected by processing conditions during its molding process and have a crimped or wavy elongated appearance, rather than a rectangular parallelepiped structure with a smooth surface.
在本實施例中,相對於聚對苯二甲酸乙二酯纖維,膠原蛋白的含量例如是1 wt%至4 wt%。更詳細而言,聚對苯二甲酸乙二酯纖維的膠原蛋白表面處理可包括以下步驟。首先,將膠原蛋白溶解於醋酸中,使溶液的pH值介於例如2.5至3.5,且膠原蛋白在醋酸中的固含量例如是0.01 wt%至0.1 wt%。之後,加入PBS以模擬生長環境,以NaOH溶液調整pH值到例如7至8,使聚對苯二甲酸乙二酯纖維與膠原蛋白反應。舉例來說,聚對苯二甲酸乙二酯纖維與膠原蛋白的反應時間例如是12小時至48小時,例如是在溫度36.5℃下反應36小時。In this embodiment, the content of collagen relative to the polyethylene terephthalate fiber is, for example, 1 wt% to 4 wt%. In more detail, the collagen surface treatment of polyethylene terephthalate fibers may include the following steps. First, the collagen is dissolved in acetic acid so that the pH of the solution is, for example, 2.5 to 3.5, and the solid content of the collagen in the acetic acid is, for example, 0.01 wt% to 0.1 wt%. After that, PBS is added to simulate the growth environment, and the pH value is adjusted to, for example, 7 to 8 with NaOH solution to make the polyethylene terephthalate fiber react with the collagen. For example, the reaction time between polyethylene terephthalate fiber and collagen is, for example, 12 hours to 48 hours, for example, the reaction time is 36 hours at a temperature of 36.5°C.
本發明也提供一種纖維製品,使用上述具有細胞親和性的纖維所製成,纖維製品可包括人工韌帶。人工韌帶的編織方法可包括平面編織或立體編織,且人工韌帶的強度例如是1500 N至3000 N,以符合人工韌帶的使用標準。The present invention also provides a fiber product, which is made by using the above-mentioned cell-affinity fiber, and the fiber product may include an artificial ligament. The weaving method of the artificial ligament may include flat knitting or three-dimensional knitting, and the strength of the artificial ligament is, for example, 1500 N to 3000 N, so as to meet the standard for the use of artificial ligaments.
以下,藉由實驗例來詳細說明上述實施例之具有細胞親和性的纖維及使用其所製成的纖維製品。然而,下述實驗例並非用以限制本發明。實驗例 Hereinafter, experimental examples are used to describe in detail the cell-affinity fibers of the above-mentioned embodiments and the fiber products made using them. However, the following experimental examples are not intended to limit the present invention. Experimental example
為了證明本發明所提出之具有細胞親和性的纖維及使用其所製成的纖維製品能夠增加纖維表面積、提升細胞及/或材料貼覆性並提升細胞組織相容性,以下特別做此實驗例。In order to prove that the fiber with cell affinity proposed by the present invention and the fiber products made by using it can increase the surface area of the fiber, improve the adhesion of cells and/or materials, and improve the compatibility of cell tissues, the following experiment is specially made. .
必須說明的是,由於具有細胞親和性的纖維之製備方法已於上文中詳細地描述,因此,下文中有關具有細胞親和性的纖維之製備,為求方便說明故省略製備細節之敘述。製備纖維 It must be noted that since the preparation method of the cell-affinity fiber has been described in detail above, the preparation of the cell-affinity fiber is omitted below for the convenience of description. Prepare fiber
分別將具有圓形斷面、十字斷面及一字斷面的聚對苯二甲酸乙二酯纖維經膠原蛋白表面處理,膠原蛋白的反應濃度以及膠原蛋白含量如下方表1所示。表 1
使用的細胞為iPS,測試條件如下: (1) 將樣本固定於細胞培養盤中,取100λ,濃度為1×105 細胞/mL的細胞懸浮液體,加入96孔盤中,在含有5 mol% CO2 、溫度37℃中培養24小時。 (2) 取出樣本後,加入100λ配置完成的試驗物質萃取樣本中的細胞後,在含有5 mol% CO2 、溫度37℃中培養24小時。 (3) 將液體置換成100λ的MTT溶液(1mg/mL MTT 溶於無血清之細胞培養液),在含有5 mol% CO2 、溫度37℃中培養1小時。 (4) 酵素免疫分析儀器,以波長540nm 進行分析,將原始數據進行分析。The cells used are iPS, and the test conditions are as follows: (1) Fix the sample in a cell culture dish, take 100λ, a cell suspension with a concentration of 1×10 5 cells/mL, and add it to a 96-well dish with a concentration of 5 mol% Incubate in CO 2 at 37°C for 24 hours. (2) After taking out the sample, add the test substance prepared with 100λ to extract the cells in the sample, and then incubate for 24 hours at 37°C containing 5 mol% CO 2 . (3) Replace the liquid with 100λ MTT solution (1mg/mL MTT dissolved in serum-free cell culture medium), and incubate for 1 hour at 37°C containing 5 mol% CO 2 . (4) The enzyme immunoassay instrument uses a wavelength of 540nm for analysis and analyzes the original data.
針對表1的纖維進行細胞貼附效能測試,將測試得到的細胞增生率列於下方表2中。由下方表2可得知,比較纖維本身細胞貼附效果,十字斷面PET纖維細胞增生率較圓形斷面PET纖維提升50%。經過膠原蛋白表面處理後,細胞增生率皆有250%以上的成長。表 2
綜上所述,本發明提供一種具有細胞親和性的纖維,其為經膠原蛋白表面處理的聚對苯二甲酸乙二酯纖維,且具有異形斷面。如此一來,能夠增加纖維表面積及粗糙度、提升細胞及/或材料貼覆性並提升細胞組織相容性,因此,可克服現有產品生物相容性不足、表面親水性差以及不利細胞貼附的缺點。另一方面,本發明也提供一種纖維製品,是使用上述具有細胞親和性的纖維所製成,纖維製品包括人工韌帶。In summary, the present invention provides a cell-affinity fiber, which is a polyethylene terephthalate fiber treated with collagen and has a special-shaped cross section. In this way, it can increase the fiber surface area and roughness, improve cell and/or material adhesion, and improve cell tissue compatibility. Therefore, it can overcome the lack of biocompatibility, poor surface hydrophilicity and unfavorable cell adhesion of existing products. Disadvantages. On the other hand, the present invention also provides a fiber product, which is made by using the above-mentioned cell-affinity fiber, and the fiber product includes an artificial ligament.
雖然本發明已以實施例揭露如上,然其並非用以限定本發明,任何所屬技術領域中具有通常知識者,在不脫離本發明的精神和範圍內,當可作些許的更動與潤飾,故本發明的保護範圍當視後附的申請專利範圍所界定者為準。Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field can make some changes and modifications without departing from the spirit and scope of the present invention. The scope of protection of the present invention shall be determined by the scope of the attached patent application.
無。no.
無。no.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108119206A TWI692559B (en) | 2019-06-03 | 2019-06-03 | Fiber with cell affinity and fiber product made using the same |
CN202010042617.5A CN112030556A (en) | 2019-06-03 | 2020-01-15 | Fiber with cell affinity and fiber product prepared by using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108119206A TWI692559B (en) | 2019-06-03 | 2019-06-03 | Fiber with cell affinity and fiber product made using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI692559B TWI692559B (en) | 2020-05-01 |
TW202045786A true TW202045786A (en) | 2020-12-16 |
Family
ID=71895849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108119206A TWI692559B (en) | 2019-06-03 | 2019-06-03 | Fiber with cell affinity and fiber product made using the same |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112030556A (en) |
TW (1) | TWI692559B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220202990A1 (en) * | 2020-12-29 | 2022-06-30 | Industrial Technology Research Institute | Tissue scaffold for use in tendon and/or ligament |
TWI765500B (en) * | 2020-12-29 | 2022-05-21 | 財團法人工業技術研究院 | Tissue scaffold for use in tendon and/or ligament |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5157111A (en) * | 1991-05-02 | 1992-10-20 | Pachence James M | Method of bonding collagen to fibers, particularly dacron |
US7947069B2 (en) * | 1999-11-24 | 2011-05-24 | University Of Washington | Medical devices comprising small fiber biomaterials, and methods of use |
DE60228573D1 (en) * | 2001-05-30 | 2008-10-09 | Chisso Corp | NETWORKED ELASTIN AND METHOD FOR THE PRODUCTION THEREOF |
CN1181232C (en) * | 2002-10-25 | 2004-12-22 | 中国皮革和制鞋工业研究院 | Collagen protein composite fiber and its producing method |
CN104043151B (en) * | 2013-03-15 | 2016-03-30 | 深圳兰度生物材料有限公司 | A kind of combined artificial ligament and preparation method thereof |
AU2016285906A1 (en) * | 2015-06-29 | 2017-12-21 | Modern Meadow, Inc. | Fabrics and methods of making them from cultured cells |
CN108653811B (en) * | 2017-03-28 | 2021-03-12 | 上海微创医疗器械(集团)有限公司 | Artificial ligament and preparation method thereof |
-
2019
- 2019-06-03 TW TW108119206A patent/TWI692559B/en active
-
2020
- 2020-01-15 CN CN202010042617.5A patent/CN112030556A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN112030556A (en) | 2020-12-04 |
TWI692559B (en) | 2020-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lai et al. | Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering | |
Chen et al. | Dual function of glucosamine in gelatin/hyaluronic acid cryogel to modulate scaffold mechanical properties and to maintain chondrogenic phenotype for cartilage tissue engineering | |
US20150297371A1 (en) | Nanocrystalline cellulose materials and methods for their preparation | |
Kim et al. | Molecular directionality in cellulose polymorphs | |
Fink et al. | Bacterial cellulose modified with xyloglucan bearing the adhesion peptide RGD promotes endothelial cell adhesion and metabolism—a promising modification for vascular grafts | |
Swindle-Reilly et al. | The impact of laminin on 3D neurite extension in collagen gels | |
Xiang et al. | Edible films for cultivated meat production | |
US20160194378A1 (en) | Peptides and uses thereof | |
Almeida et al. | Tropoelastin-coated tendon biomimetic scaffolds promote stem cell tenogenic commitment and deposition of elastin-rich matrix | |
Lai | Corneal stromal cell growth on gelatin/chondroitin sulfate scaffolds modified at different NHS/EDC molar ratios | |
CN103333508A (en) | Collagen hydrogel for injection and preparation method thereof | |
JP2005528933A (en) | Cross-linked bioactive hydrogel matrix | |
Reynolds | Amyloid-like peptide nanofibrils as scaffolds for tissue engineering: Progress and challenges | |
TW202045786A (en) | Fiber with cell affinity and fiber product made using the same | |
Millon et al. | Exploring cell compatibility of a fibronectin‐functionalized physically crosslinked poly (vinyl alcohol) hydrogel | |
Liu et al. | Hydrophilic modification on polyvinyl alcohol membrane by hyaluronic acid | |
US20170360986A1 (en) | Collagenous tissue repair device | |
Goel | Surgical sutures-a review | |
Chen et al. | Collagen membrane derived from fish scales for application in bone tissue engineering | |
Cuartas-Marulanda et al. | Natural coatings and surface modifications on magnesium alloys for biomedical applications | |
Kulkarni et al. | Utilization of fish collagen in pharmaceutical and biomedical industries: waste to wealth creation | |
Linh et al. | Fabrication and in vitro evaluations with osteoblast-like MG-63 cells of porous hyaluronic acid-gelatin blend scaffold for bone tissue engineering applications | |
Abbasnezhad et al. | Chemical modification of acellular fish skin as a promising biological scaffold by carbodiimide cross‐linker for wound healing | |
CN114146223A (en) | Recombinant collagen compound injection and preparation method thereof | |
Travnickova et al. | Differentiation of adipose tissue-derived stem cells towards vascular smooth muscle cells on modified poly (L-lactide) foils |